Search

Author/Creator Strub, Jean-Marc

1. A Pilot Study on Continuous Infusion of 4% Albumin in Critically Ill Patients: Impact on Nosocomial Infection via a Reduction Mechanism for Oxidized Substrates. (September 2019)

Authors:
Schneider, Francis; Dureau, Anne-Florence; Hellé, Sophie; Betscha, Cosette; Senger, Bernard; Cremel, Gérard; Boulmedais, Fouzia; Strub, Jean-Marc; Corti, Angelo; Meyer, Nicolas; Guillot, Max; Schaaf, Pierre; Metz-Boutigue, Marie-Hélène
Journal:
Critical care explorations
Issue:
Volume 1:Number 9(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR. (21st February 2019)

Authors:
Groysbeck, Nadja; Stoessel, Audrey; Donzeau, Mariel; da Silva, Elisabete Cruz; Lehmann, Maxime; Strub, Jean-Marc; Cianferani, Sarah; Dembélé, Kassiogé; Zuber, Guy
Journal:
Nanotechnology
Issue:
Volume 30:Number 18(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice. Issue 12 (26th November 2014)

Authors:
Martin, Perrine; Dubois, Clarisse; Jacquier, Emilie; Dion, Sarah; Mancini-Bourgine, Maryline; Godon, Ophélie; Kratzer, Roland; Lelu-Santolaria, Karine; Evlachev, Alexei; Meritet, Jean-François; Schlesinger, Yasmin; Villeval, Dominique; Strub, Jean-Marc; Van Dorsselaer, Alain; Marchand, Jean-Bapti...
Journal:
Gut
Issue:
Volume 64:Issue 12(2015)
Page Start:
1961
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗